Palantir Technologies is currently worth $360 billion, but Shopify and AppLovin could top that figure within five years. Shopify has added AI features to its platform and integrated merchants' product ...

Eaton (ETN) is a Buy, with a target price of $373, reflecting more conservative growth assumptions and a 7% upside from ...

Flash floods are among the deadliest weather events in the world, killing more than 5,000 people each year. They’re also among the most difficult to predict. But Google thinks it has cracked that ...

LinkedIn’s latest report highlights the 10 fastest-growing tech jobs in 2026, including AI engineers, consultants, and data center technicians.

This research initiative highlights the importance of ethical and explainable artificial intelligence in workforce ...

LONDON, Feb 18 (Reuters) - UBS lifted its 2026 forecasts for U.S. tech investment grade bond sales on Wednesday, pointing to rising spending by big tech firms, while cutting its forecast for leveraged ...

Novo Nordisk’s U.S.-traded shares slid 15% Tuesday after the drugmaker unexpectedly warned that its 2026 sales would decline more sharply than expected, as pricing pressure weighs on U.S. sales of its ...

Up to a foot is possible this weekend in parts of the Southeast and on Cape Cod, with smaller amounts expected for much of the East Coast. Source: National Weather Service. Aatish Bhatia, William B.

Nvidia (NVDA) has released Earth-2, its artificial intelligence models and tools for generating 15-day global and local weather forecasts, which, coincidentally, is at the same time a severe winter ...

EV sales momentum slows in 2026 with the global auto market under pressure; The top-3 EV markets see their EV development heading in different directions, shrinking annual growth to 15.2% for the year ...

American Eagle stock jumped on Wednesday after the retailer boosted its sales forecast as the apparel company continued to see traffic increase following its viral Sydney Sweeney jeans campaign. The ...

Swiss drugmaker Novartis on Thursday forecast sales growth of 5% to 6% per year to 2030, on a currency-adjusted basis, as higher forecast peak sales for cancer drugs Kisqali and Scemblix offset losses ...